Related Experiment Video

Updated: Jul 14, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome

Sana Salih1, Xia Xu, Timothy D Veenstra

  • 1Department of Obstetrics and Gynecology, University of Texas Medical Branch, 301 University Boulevard, Galveston, Texas 77555-0587, USA.

The Journal of Clinical Endocrinology and Metabolism
|May 31, 2007
PubMed
Abstract

Insights

Polycystic ovary syndrome (PCOS) is linked to lower 2-hydroxyestrogen levels, potentially due to increased ovarian expression of catechol-O-methyl transferase (COMT). Further research is needed to understand estrogen metabolism

Area of Science:

  • Endocrinology
  • Reproductive Biology
  • Metabolic Disorders

Background:

  • Polycystic ovary syndrome (PCOS) is characterized by anovulation linked to impaired follicular maturation.
  • Catechol-O-methyl transferase (COMT) substrates and products influence granulosa cell proliferation and angiogenesis.

Purpose of the Study:

  • To investigate ovarian COMT expression and estrogen metabolite production in women with PCOS.
  • To evaluate the relationship between estrogen metabolism and PCOS.

Main Methods:

  • Ovarian tissue and urine samples were collected from women with PCOS and healthy controls.
  • Immunohistochemistry assessed COMT protein expression in ovarian tissues.
  • Urinary estrogen metabolites were quantified using immunoassays and liquid chromatography-tandem mass spectrometry.

Main Results:

  • COMT expression was significantly higher in the ovaries of women with PCOS compared to controls.
  • Urinary 2-hydroxyestrogen levels were significantly lower in women with PCOS.
  • Lower urinary 2-hydroxyestrogen levels correlated with higher serum insulin levels in PCOS patients.

Conclusions:

  • Reduced urinary 2-hydroxyestrogen in PCOS may be associated with increased ovarian COMT expression.
  • Estrogen metabolism plays a role in PCOS pathophysiology.
  • Further investigation is required to establish clinical applications of these findings.

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice04:49

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice

Published on: July 5, 2024

Related Concept Videos

Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...